Sign up for our free newsletter and get more of Development Asia delivered to your inbox.
This presentation gives an overview on the Regulatory Strengthening Program (RSP) by TGA in the Indo-Pacific region to improve pharmacovigilance systems and address challenges in regulatory frameworks, fragmented systems, underreporting of adverse events, and collaboration issues.
Disclaimer
The views expressed on this website are those of the authors and do not necessarily reflect the views and policies of the Asian Development Bank (ADB) or its Board of Governors or the governments they represent. ADB does not guarantee the accuracy of the data included in this publication and accepts no responsibility for any consequence of their use. By making any designation of or reference to a particular territory or geographic area, or by using the term “country” in this document, ADB does not intend to make any judgments as to the legal or other status of any territory or area.
